Key result
Clinico-molecular integration clarifies oncocytic transformation and highlights pathologist roles in hereditary cancers.
Why the study?
Only a limited subset of familial neoplastic syndromes includes tumors with distinctive oncocytic features, necessitating further investigation by pathologists and clinicians in affected patients and their families.
Recognizing syndromic associations of oncocytic tumors through histopathological clues and genetic testing is crucial for accurate diagnosis and tailored management of hereditary cancer syndromes.
Alerts clinicians to familial syndromes in oncocytic tumors; extends genetic links but leaves validation to prospective studies.
BACKGROUND: Familial neoplastic syndromes are distinguished by the presence of specific neoplasms which serve as critical indicators for their suspicion and diagnosis. Among these, only a limited subset includes tumors with distinctive oncocytic features, highlights the necessity for pathologists and clinicians to pursue further investigation in affected patients and their families. SUMMARY: Advances in genetic research and diagnostic pathology have highlighted the germline predispositions underlying these tumors, which manifest across multiple organ systems, including thyroid, parathyroid, renal, and adrenal glands. This review examines the clinical, pathological, and molecular features of oncocytic neoplasms in the context of hereditary syndromes such as Carney complex, Li-Fraumeni syndrome, DICER1 syndrome, Birt-Hogg-Dubé syndrome, hyperparathyroidism-jaw tumor syndrome, hereditary leiomyomatosis and renal cell carcinoma syndrome, tuberous sclerosis syndrome, Beckwith-Wiedemann syndrome, and SDH-deficient hereditary paraganglioma/pheochromocytoma syndrome. It emphasizes the importance of recognizing syndromic associations through histopathological clues, genetic testing, and family history to facilitate accurate diagnosis and tailored management. KEY MESSAGE: By integrating clinical insights with molecular data, this paper sheds light on the mechanisms driving oncocytic transformation and underscores the role of pathologists in identifying hereditary cancer syndromes.
No takes yet. Share an insight, caveat, or question.
Riascos et al. (2025) conducted a review in Oncocytic Tumors in Familial and Syndromic Contexts. Integrating clinical insights with molecular data sheds light on the mechanisms driving oncocytic transformation and underscores the role of pathologists in identifying hereditary cancer syndromes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: